Chenodeoxycholic Acid

Chenodeoxycholic acid (CDCA) is a primary bile acid synthesized in the liver from cholesterol. It is the most abundant bile acid in human bile and plays a critical role in lipid digestion and absorption. This product is supplied as a white to off-white crystalline powder with ≥98% purity (HPLC), specifically graded for pharmaceutical and research applications.

CDCA is used as an active pharmaceutical ingredient (API) in the treatment of gallstones (cholelithiasis) and is also a key intermediate in the synthesis of other bile acids like ursodeoxycholic acid (UDCA). Its amphipathic nature makes it valuable in formulation science, particularly for enhancing drug solubility and bioavailability.

Синонимы: Chenodeoxycholic acid, CDCA, 3α,7α-Dihydroxy-5β-cholanic acid, 5β-Cholanic acid-3α,7α-diol, Chenodiol, Chenix, 474-25-9

Приложения

• API for gallstone dissolution therapy (pharmaceutical formulations)
• Starting material for semi-synthetic bile acid derivatives (e.g., UDCA)
• Research reagent in lipid metabolism and bile acid signaling studies
• Excipient or solubilizer in drug delivery systems

Качество и документация

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤1.0%), heavy metals (≤10 ppm), and residual solvents. Full COA, MSDS, and TDS are available on request. Stability data can be provided for qualification purposes.

Упаковка и поставки

Standard packaging: 1 kg, 5 kg, 25 kg. Bulk and custom packing available. In-stock items ship within 3-5 days; MOQ from 1 kg. For pricing, samples, and bulk orders, contact our sales team.

Запрос Цитировать

• Наш адрес: 280 Main Street, Сиань, провинция Шэньси, Китай
• LyvBio Co., Ltd. — Электронная почта: info@lyvbio.com